- Home
- HIND vs VYNE Comparison
HIND vs VYNE Comparison
Compare HIND & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIND
- VYNE
- Stock Information
- Founded
- HIND N/A
- VYNE 2003
- Country
- HIND United States
- VYNE United States
- Employees
- HIND N/A
- VYNE N/A
- Industry
- HIND
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- HIND
- VYNE Health Care
- Exchange
- HIND Nasdaq
- VYNE Nasdaq
- Market Cap
- HIND 10.3M
- VYNE 9.6M
- IPO Year
- HIND 2016
- VYNE 2018
- Fundamental
- Price
- HIND $5.53
- VYNE $0.35
- Analyst Decision
- HIND
- VYNE Buy
- Analyst Count
- HIND 0
- VYNE 2
- Target Price
- HIND N/A
- VYNE $8.00
- AVG Volume (30 Days)
- HIND N/A
- VYNE 3.1M
- Earning Date
- HIND N/A
- VYNE 11-10-2025
- Dividend Yield
- HIND N/A
- VYNE N/A
- EPS Growth
- HIND N/A
- VYNE N/A
- EPS
- HIND N/A
- VYNE N/A
- Revenue
- HIND N/A
- VYNE $476,000.00
- Revenue This Year
- HIND N/A
- VYNE N/A
- Revenue Next Year
- HIND N/A
- VYNE N/A
- P/E Ratio
- HIND N/A
- VYNE N/A
- Revenue Growth
- HIND N/A
- VYNE N/A
- 52 Week Low
- HIND N/A
- VYNE $0.28
- 52 Week High
- HIND N/A
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- HIND 46.05
- VYNE 45.19
- Support Level
- HIND $5.31
- VYNE $0.34
- Resistance Level
- HIND $5.70
- VYNE $0.38
- Average True Range (ATR)
- HIND 0.37
- VYNE 0.03
- MACD
- HIND 0.13
- VYNE 0.00
- Stochastic Oscillator
- HIND 64.57
- VYNE 16.76
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.